Aepodia provides clinical due diligence support for preclinical pharmacology data to phase II clinical data to evaluate the: pertinence of the available preclinical and clinical data; interpretation of the available compound information; level of quality and regulatory compliance; and robustness of the IP. We present our results in a technical report that includes a SWOT analysis. We draw on a network of consultants and experts in toxicology, preclinical drug metabolism, chemistry, GLP, GMP and more to ensure effective and complete due diligence.

Need more information from the seller?

Share on: